With Expert’Biome, the company will offer further product development services, including strain R&D, bioprocess scaling, drug manufacturing, and other steps.
The company will showcase strains and capabilities in areas such as gut health, women’s health, the gut-brain axis, and delivery and dosage technologies.
The impact of Lallemand’s L. rhamnosus HA-114 on eating and mood-related behaviors could facilitate adherence to weight loss programs, the study found.